  | Rousseau, A.-F., Misset, B., MASSENET, V., Lecart, M.-P., & Kaux, J.-F. (April 2023). Métabolisme osseux et risque de fracture après séjour aux soins intensifs. Ortho-Rhumato, 21 (2), 16-18. |
  | ROUSSEAU, A.-F., DEROISY, R., LECART, M.-P., MASSENET, V., SARLET, N., Misset, B., CAVALIER, E., & KAUX, J.-F. (2022). Bone health in survivors of a prolonged ICU stay. Aging Clinical and Experimental Research, 34 (S1), 332.  Peer Reviewed verified by ORBi |
 | Willers, C., Norton, N., Harvey, N. C., Jacobson, T., Johansson, H., Lorentzon, M., McCloskey, E. V., Borgström, F., Kanis, J. A., Kaux, J.-F. (Other coll.), Reginster, J.-Y. (Other coll.), Bruyère, O. (Other coll.), Cavalier, E. (Other coll.), & LECART, M.-P. (Other coll.). (January 2022). Osteoporosis in Europe: a compendium of country-specific reports. Archives of Osteoporosis, 17 (1), 23. doi:10.1007/s11657-021-00969-8 Peer Reviewed verified by ORBi |
 | DEROISY, R., NEUPREZ, A., LEONARD, Y., LECART, M.-P., MASSENET, V., GILLET, P., Reginster, J.-Y., & KAUX, J.-F. (December 2020). Identification, through a Fracture Liaison Service, of undiagnosed vertebral fractures in patients hospitalized for a prevalent hip fragility fracture. Osteoporosis International, 31 (S1), 200. Peer Reviewed verified by ORBi |
 | NEUPREZ, A., DEROISY, R., LEONARD, Y., LECART, M.-P., MASSENET, V., GILLET, P., KAUX, J.-F., & Reginster, J.-Y. (December 2020). Secondary fracture prevention in hip fracture patients: 6-year impact of a Fracture Liaison Service. Osteoporosis International, 31 (S1), 199-200. Peer Reviewed verified by ORBi |
 | BETHLEN, S., Bornheim, S., Delvaux, F., Marquet, L., Pelzer, D., NEUPREZ, A., Lecart, M.-P., MAERTENS DE NOORDHOUT, B., WANG, F.-C., Tomasella, M., Croisier, J.-L., SERVAIS, D., GÖBELS, C., & Kaux, J.-F. (May 2020). Innovations en médecine physique et réadaptation. Revue Médicale de Liège, 75 (5-6), 445-451. Peer reviewed |
 | Kaux, J.-F., LECART, M.-P., & NEUPREZ, A. (19 January 2019). How to improve the care path of osteoporotic patients? [Paper presentation]. Belgian Bone Club Clinical Update Symposium, Brussels, Belgium. |
 | Rabenda, V., Bruyère, O., Cavalier, E., DEROISY, R., LECART, M.-P., COLLETTE, J., & Reginster, J.-Y. (2015). Serum concentrations of osteoprotegerin (OPG) and dickkope-1 (DKK1) poorly predict bone mineral density changes and fracture incidence in postmenopausal osteoporotic women. Osteoporosis International, 26 (S1), 240. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., NEUPREZ, A., LECART, M.-P., Beaudart, C., Buckinx, F., Slomian, J., & Bruyère, O. (2015). Ostéoporose et Médecine Personnalisée. Revue Médicale de Liège, 70 (5-6), 321-324. Peer reviewed |
 | Reginster, J.-Y., NEUPREZ, A., Beaudart, C., LECART, M.-P., Sarlet, N., Bernard, D., Distèche, S., & Bruyère, O. (2014). Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis. Drugs and Aging, 31, 413-424. doi:10.1007/s40266-014-0179-z Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., NEUPREZ, A., LECART, M.-P., Sarlet, N., Distèche, S., & Bruyère, O. (2014). Traitement de l'osteoporose post-menopausique: quoi de neuf en 2014? Revue Médicale de Liège, 69 (7-8), 441-53. Peer reviewed |
 | REGINSTER, J.-Y., Neuprez, A., LECART, M.-P., SARLET, N., & Bruyère, O. (October 2012). Role of glucosamine in the treatment for osteoarthritis. Rheumatology International, 32 (10), 2959-67. doi:10.1007/s00296-012-2416-2 Peer Reviewed verified by ORBi |
 | LECART, M.-P., & Reginster, J.-Y. (2011). Current options for the management of postmenopausal osteoporosis. Expert Opinion on Pharmacotherapy, 12 (16), 2533-52. doi:10.1517/14656566.2011.618123 Peer Reviewed verified by ORBi |
 | Maquet, D., BRONFORT, S., LECART, M.-P., FAYMONVILLE, M.-E., Croisier, J.-L., & Crielaard, J.-M. (June 2010). Effects of original rehabilitation programs in patients with fibromyalgia syndrome. Annals of the Rheumatic Diseases, 69 (Suppl 3), 706. Peer Reviewed verified by ORBi |
 | Maquet, D., BRONFORT, S., LECART, M.-P., FAYMONVILLE, M.-E., Croisier, J.-L., & Crielaard, J.-M. (June 2010). Effects of an original training program in healthy elderly subjects. Annals of the Rheumatic Diseases, 69 (Suppl 3), 313. Peer Reviewed verified by ORBi |
 | Lecart, M.-P., & Cavalier, E. (2009). La vitamine D dans tous ses états: effets pleiotropes de la vitamine D [Paper presentation]. 7èmes Journées de l'Enseignement post-universitaire de la Faculté de Médecine de l'Université de Liège, Liège, Belgium. |
 | Maquet, D., Lehance, C., Mouette, E., Grosdent, S., Lecart, M.-P., Faymonville, M., Bury, T., Crielaard, J.-M., & Croisier, J.-L. (2008). Sensibilité d’une épreuve de monitoring fonctionnel de 24 h dans le cadre du suivi du fibromyalgique au cours d’un programme de revalidation aérobie. Revue du Rhumatisme, 75, 1141. Peer Reviewed verified by ORBi |
 | Maquet, D., Lehance, C., Vickevorst, G., Faymonville, M., Lecart, M.-P., Crielaard, J.-M., Bury, T., & Croisier, J.-L. (2008). Etablissement de données normatives relatives à l’activité physique journalière de la population générale. Revue du Rhumatisme, 75, 1019. Peer Reviewed verified by ORBi |
 | Maquet, D., Jaspar, J., Lecart, M.-P., Faymonville, M., Crielaard, J.-M., Bève, E., Ansseau, M., Pinto, E., Haidon, M., & Croisier, J.-L. (2008). La marche du sujet fibromyalgique et d’un sujet dépressif est-elle différenciable ? Exploration de deux affections « voisines » à partir d’un accéléromètre tri-axial. Revue du Rhumatisme, 75, 1142. Peer reviewed |
Maquet, D., Demoulin, C., Lecart, M.-P., Faymonville, M., Croisier, J.-L., & Crielaard, J.-M. (2007). Influence of specific rehabilitation programs on pressure pain thresholds in patients with fibromyalgia or chronic low back pain. Annals of the Rheumatic Diseases, 66, 423-424. Peer Reviewed verified by ORBi |
 | Demoulin, C., Maquet, D., Delcourt, D., Grosdent, S., Lecart, M.-P., Croisier, J.-L., Vanderthommen, M., Crielaard, J.-M., & Depaifve, A. (Other coll.). (2007). Explorations algo-fonctionnelles comparatives entre populations fibromyalgique et lombalgique chronique. Revue du Rhumatisme, 74 (10-11), 982. Peer Reviewed verified by ORBi |
Maquet, D., Vanderthommen, M., Lecart, M.-P., Demoulin, C., Leroy-Willig, A., Croisier, J.-L., Crielaard, J.-M., & Carlier, P. (2007). Use of magnetic resonance imaging and 31p-spectroscopy to explore muscle energetics in fibromyalgia patients. Annals of the Rheumatic Diseases, 66, 424. Peer Reviewed verified by ORBi |
Maquet, D., Demoulin, C., Croisier, J.-L., Lecart, M.-P., Faymonville, M., & Crielaard, J.-M. (2006). Intérêts de la revalidation musculaire progressive dans la prise en charge de la fibromyalgie. Revue du Rhumatisme, 73, 1103. Peer Reviewed verified by ORBi |
 | Richy, F., Lecart, M.-P., Mawet, A., Paquot, B., & Reginster, J.-Y. (2006). Interet de la densitometrie osseuse dans le depistage et le suivi therapeu- tique des patients osteoporotiques: integration avec les facteurs cliniques et biologiques. Revue Médicale de Liège, 61 (5-6, May-Jun), 291-300. Peer reviewed |
Maquet, D., Demoulin, C., Croisier, J.-L., Lecart, M.-P., Faymonville, M., & Crielaard, J.-M. (2006). Etude de la sensibilité à la douleur : comparaison entre populations contrôle et fibromyalgique. Revue du Rhumatisme, 73, 1038-1039. Peer Reviewed verified by ORBi |
Maquet, D., Demoulin, C., Croisier, J.-L., Lecart, M.-P., Faymonville, M., & Crielaard, J.-M. (2006). Etude comparative des qualités musculaires entre populations fibromyalgique et lombalgique. Revue du Rhumatisme, 73, 1107-1108. Peer Reviewed verified by ORBi |
 | Richy, F., Deroisy, R., Lecart, M.-P., Hanssens, L., Mawet, A., & Reginster, J.-Y. (April 2005). D-Hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management. Aging Clinical and Experimental Research, 17 (2), 133-142. doi:10.1007/BF03324586 Peer Reviewed verified by ORBi |
 | Richy, F., DEROISY, R., LECART, M.-P., Hanssens, L., Schacht, E., & Reginster, J.-Y. (March 2005). D-hormone analog alfacalcidol: its role in postmenopausal osteoporosis and rheumatoid arthritis management. Osteoporosis International, 16 (Suppl.3), 105-106. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., LECART, M.-P., Bruyère, O., & Burlet, N. (2005). Glucosamine sulphate in osteoarthritis: from symptoms to structure modification. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, 4, 217-220. doi:10.2174/1568014054065212 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Burlet, N., & LECART, M.-P. (2005). Ibandronate: a new perspective in the treatment of osteoporosis. Therapy, 2, 179-189. doi:10.1586/14750708.2.2.179 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Sarlet, N., & Lecart, M.-P. (January 2005). Fractures in osteoporosis: the challenge for the new millennium. Osteoporosis International, 16 (Suppl. 1), 1-S3. doi:10.1007/s00198-004-1752-9 Peer Reviewed verified by ORBi |
 | REGINSTER, J.-Y., LECART, M.-P., DEROISY, R., & Lousberg, C. (2004). Strontium ranelate: a new paradigm in the treatment of osteoporosis. Expert Opinion on Investigational Drugs, 13 (7), 857-64. doi:10.1517/13543784.13.7.857 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., & LECART, M.-P. (2004). Treatment of osteoporosis with biphosphonates - Do compliance and persistence matter ? Business briefing : Long-term Healthcare, 5, 65-68. Peer reviewed |
 | Reginster, J.-Y., LECART, M.-P., & SARLET, N. (2004). Traitement structurel de l'arthrose : le point en 2004. Ortho-Rhumato, 2 (3), 52-54. Peer reviewed |
 | Reginster, J.-Y., Bruyère, O., Lecart, M.-P., & Henrotin, Y. (September 2003). Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis. Current Opinion in Rheumatology, 15, 651-655. doi:10.1097/00002281-200309000-00022 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Lecart, M.-P., Sarlet, N., & Halkin, V. (2003). Prevention de la fracture de la hanche chez le sujet age: ou en sommes-nous en 2003? Revue Médicale de Liège, 58 (4), 183-90. Peer reviewed |
 | Reginster, J.-Y., DEROISY, R., LECART, M.-P., Zegels, B., Denis, D., SARLET, N., Reginster-Haneuse, G., Albert, A., & Boelen, C. (1996). Prévention de l’ostéoporose à Liège. Histoire d’un PIGEPS : dix ans plus tard. Santé Publique: Revue Multidisciplinaire pour la Recherche et l'Action, 2, 139-150. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Lecart, M.-P., Deroisy, R., Ethgen, D., Zegels, B., & Franchimont, P. (January 1993). Paget's Disease of Bone Treated with a Five Day Course of Oral Tiludronate. Annals of the Rheumatic Diseases, 52 (1), 54-7. doi:10.1136/ard.52.1.54 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., DEROISY, R., LECART, M.-P., Zegels, B., Sarlet, N., de Longueville, M., Albert, A., & Franchimont, P. (1993). Nasal salmon calcitonin for prevention of early postmenopausal bone loss: a dose-ranging placebo controlled study. Journal of Bone and Mineral Research, 8 (S1), 340. Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Deroisy, R., Albert, A., Denis, D., Lecart, M.-P., Collette, J., & Franchimont, P. (March 1989). Relationship between Whole Plasma Calcitonin Levels, Calcitonin Secretory Capacity, and Plasma Levels of Estrone in Healthy Women and Postmenopausal Osteoporotics. Journal of Clinical Investigation, 83 (3), 1073-7. doi:10.1172/JCI113950 Peer Reviewed verified by ORBi |
Lecart, M.-P., Cormann, N., Heinen, E., Kinet-Denoel, C., & Simar, L. J. (1989). Etude de la proliferation lymphocytaire humaine in vitro en reponse a l'anatoxine tetanique. Revue Médicale de Liège, 44 (13-14), 455-63. Peer reviewed |
 | Reginster, J.-Y., JEUGMANS, A.-M., Albert, A., Denis, D., Deroisy, R., LECART, M.-P., Fontaine, M. A., Collette, J., & Franchimont, P. (1988). Biological and Clinical Assessment of a New Bisphosphonate, (Chloro-4 Phenyl) Thiomethylene Bisphosphonate, in the Treatment of Paget's Disease of Bone. BONE, 9 (6), 349-54. doi:10.1016/8756-3282(88)90115-9 Peer Reviewed verified by ORBi |
 | Deby, G., Braun, M., Lamy, M., Deby, C., Pincemail, J., Faymonville, M., Damas, P., Bodson, L., Lecart, M.-P., & Goutier, R. (1987). Thromboxane and prostacyclin release in adult respiratory distress syndrome. Intensive Care Medicine, 13, 167-174. doi:10.1007/BF00254700 Peer Reviewed verified by ORBi |